A study conducted by Wake Forest University Baptist Medical Center, Winston-Salem, NC shows emergency room doctors are correctly identifying patients who are having a heart attack—even when lab tests have not yet confirmed it, according to the Emergency Medicine Journal.
Read MoreRosetta Genomics Ltd, Israel and Jersey City, NJ, reports its molecular test based on proprietary microRNA technology has been approved for clinical use by the New York State Department of Health Clinical Laboratory Evaluation Program.
Read MoreCombiMatrix Molecular Diagnostics, Irvine, Calif, a subsidiary of CombiMatrix Corp, Mukilteo, Wash, is offering an updated version of its ATScan ™ test for predisposition screening for autism. The test encompasses recent discoveries publis
Read MoreGeneNews Limited, Ontario, Canada, which develops blood-based biomarker tests for early detection of diseases and personalized health management, has introduced ColonSentry, a blood-based molecular test for colorectal cancer screening.
Read MoreLabtronics Inc, Guelph, Ontario, has released an update for Collect 6.1, a software solution for interfacing and controlling instruments and devices via RS232 or TCP/IP.
Read More